Newsroom

Recent News Releases

June 5, 2019 6/5/2019 Takeda Provides Update on TOURMALINE-AL1 Phase 3 Trial in AL Amyloidosis

June 3, 2019 6/3/2019 Takeda Presents Results from Lung Portfolio Including Phase 1/2 Study of TAK-788 in a Rare Form of NSCLC and New Data on Overall Health-Related Quality of Life for ALUNBRIG^® (brigatinib)

June 3, 2019 6/3/2019 New Ad-hoc Analysis of Phase 3 HELP Study™ Evaluates Prevention of HAE Attacks with TAKHZYRO® (lanadelumab) During Early Treatment Phase

June 3, 2019 6/3/2019 Takeda Makes First Private Sector Pledge for Global Fund Replenishment

May 31, 2019 5/31/2019 Notice Regarding Pricing of Hybrid Bonds to Repay Senior Short Term Loan (Offering of Subordinated Bonds)

SEE ALL NEWS AND RELEASES >

・For legacy Shire information, click here

Featured Topics

Takeda breaks ground on a state of the art facility in Osaka, Japan

LEARN MORE

Strengthening Takeda’s Global Reach by Sustaining Core Values

LEARN MORE

Deepening Our Commitment to Research with State-of-the-Art Facility in San Diego, California

LEARN MORE

2019 Innovators in Science Award Winners Celebrated for Regenerative Medicine Research

LEARN MORE

CEO Christophe Weber on Why Takeda’s Unique Corporate Governance Structure Works

LEARN MORE

SEE ALL FEATURED TOPICS ARTICLES >

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.